title: Safety and efficacy of up to 900 mg/day polysulfate sodium (elmiron) in patients with interstitial cystitis.
authors.affiliation: Queens University, Kingston, Ontario, Canada.
authors.forename: J C
authors.initials: JC
authors.lastname: Nickel
authors.forename: J
authors.initials: J
authors.lastname: Forrest
authors.forename: J
authors.initials: J
authors.lastname: Barkin
authors.forename: C
authors.initials: C
authors.lastname: Payne
authors.forename: P
authors.initials: P
authors.lastname: Mosbaugh
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage* / Q000009:adverse effects; D018856:Cystitis, Interstitial / Q000188:drug therapy*; D006801:Humans; D010426:Pentosan Sulfuric Polyester / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D010426:Pentosan Sulfuric Polyester